Locacorten-Vioform

Land: Nya Zeeland

Språk: engelska

Källa: Medsafe (Medicines Safety Authority)

Köp det nu

Ladda ner Produktens egenskaper (SPC)
19-04-2020

Aktiva substanser:

Clioquinol 1%{relative};  ; Flumetasone pivalate 0.02%{relative}

Tillgänglig från:

AFT Pharmaceuticals Ltd

INN (International namn):

Clioquinol 1% w/v

Läkemedelsform:

Ear drops

Sammansättning:

Active: Clioquinol 1%{relative}   Flumetasone pivalate 0.02%{relative} Excipient: Macrogol 300

Enheter i paketet:

Bottle, dropper, PE dropper bottle and plastic cap x 7.5mL, 7.5 mL

Klass:

Prescription

Receptbelagda typ:

Prescription

Tillverkad av:

Synthexim

Terapeutiska indikationer:

Eczema of the external auditory meatus in which secondary infection with microorganisms sensitive to clioquinol has occurred. · Otitis externa · Otomycosis.

Produktsammanfattning:

Package - Contents - Shelf Life: Bottle, dropper, PE dropper bottle and plastic cap x 7.5mL - 7.5 mL - 18 months from date of manufacture stored at or below 25°C

Tillstånd datum:

2010-05-06

Produktens egenskaper

                                Page 1 of 9
NEW ZEALAND DATA SHEET
1.
LOCACORTEN-VIOFORM
® (1% CLIOQUINOL AND 0.02% FLUMETASONE
PIVALATE EAR DROPS)
LOCACORTEN-VIOFORM
®
1% clioquinol and 0.02% flumetasone pivalate ear drops
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
LOCACORTEN-VIOFORM
®
contains
1% clioquinol and 0.02% flumetasone pivalate.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Ear drops.
A clear yellowish solution with a volume of 7.5ml (32 ± 3 drops per
1ml). Flumetasone is a
synthetic difluorinated glucocorticoid.
Clioquinol is a halogenated hydroxyquinolone derivative.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Eczema of the external auditory meatus in which secondary infection
with micro-organisms sensitive
to clioquinol has occurred.
•
Otitis externa
•
Otomycosis.
4.2
DOSE AND METHOD OF ADMINISTRATION
Before application, the auditory meatus should be cleansed and dried
carefully.
Instill 2 or 3 drops twice daily into the auditory meatus by gently
squeezing the plastic bottle. The
patient should be either sitting or lying down with the treated ear
turned upwards during application.
This position should be maintained for at least 1-2 minutes following
the application.
Alternatively, a gauze or cotton wick saturated with the solution may
be inserted into the ear canal.
Keep the wick moistened by adding further solution. It should be
replaced at least once every 24
hours.
The solution may be warmed to body temperature prior to each
application (e.g. by holding the bottle
Page 2 of 9
in the hands). Heating above body temperature should be avoided.
Contamination of the dropper with
material from the ear, fingers, or other sources should be avoided.
Treatment should normally not
exceed 10 days.
LOCACORTEN-VIOFORM
®
is dissolved in a polyethylene glycol vehicle which forms an inert,
non-
irritant, rather viscous medium. This medium has a softening effect on
the cerumen and does not
prevent drainage, thus ensures prolonged contact of the active
ingredients with the surface of the ear
canal.
If no
                                
                                Läs hela dokumentet